Number of the records: 1

Prodrugs of prostate specific membrane antigen (PSMA) inhibitor

SYSNO ASEP	0559889
Document Type	P - Patent
R&D Document Type	Patent or other outcome protected by special legislation
Title	Prodrugs of prostate specific membrane antigen (PSMA) inhibitor
Author(s)	Slusher, B. (US) Rais, R. (US) Krečmerová, Marcela (UOCHB-X)_{RID, ORCID} Tichý, Tomáš (UOCHB-X)_RID Majer, Pavel (UOCHB-X) Jančařík, Andrej (UOCHB-X)_{ORCID, RID}
Year of issue	2022
Possible third party use of the result	A - Pro využití výsledku jiným subjektem je vždy nutné nabytí licence
Royalty requested	A - Poskytovatel licence požaduje licenční poplatek
Patent no. or utility model no. or industrial design no.	US11325931
Date of the patent acceptance	10.05.2022
Name of the patent owner	The Johns Hopkins University - Ústav organické chemie a biochemie AV ČR, v. v. i.
Code of the issuer name	US001 - United States Patent and Trademark Office (USPTO) Alexandria
Current use	B - Patent je využíván na základě uzavřené licenční smlouvy mezi vlastníkem a uživatelem
Language	eng - English
Keywords	2-Phosphonomethylpentanedioic acid (2-PMPA) ; glutamate carboxypeptidase II ; GCPII ; PSMA ; pivaloyloxymethyl ; isopropyloxycarbonyloxymethyl ; POM ; POC ; prodrug
OECD category	Organic chemistry
Institutional support	UOCHB-X - RVO:61388963
Annotation	Methods and compounds are disclosed for treating a disease or condition by inhibiting PSMA (Prostate Specific Membrane Antigen) using prodrugs of 2-PMPA.
Workplace	Institute of Organic Chemistry and Biochemistry
Contact	asep@uochb.cas.cz ; Kateřina Šperková, Tel.: 232 002 584 ; Viktorie Chládková, Tel.: 232 002 434
Year of Publishing	2023
Electronic address	https://worldwide.espacenet.com/patent/search/family/055264571/publication/US11325931B2?q=US11325931B2

Number of the records: 1